Long-acting β2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells

Molecular Pharmacology

Volumn 73, Issue 1, 2008, Pages 203-214

  Kaur, Manminder ^a   Chivers, Joanna E ^a   Giembycz, Mark A ^a   Newton, Robert ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; BINDING PROTEIN; BUDESONIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1C; DEXAMETHASONE; FLUTICASONE; FORMOTEROL; GLUCOCORTICOID; GLUCOCORTICOID INDUCIBLE LEUCINE ZIPPER; LEUCINE ZIPPER PROTEIN; LONG ACTING DRUG; METALLOTHIONEIN I; MICROSOMAL AMINOPEPTIDASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE INHIBITOR; SALBUTAMOL; SALMETEROL; TRISTETRAPROLIN; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SMOOTH MUSCLE FIBER; BRONCHUS; CYTOLOGY; METABOLISM; VASCULAR SMOOTH MUSCLE;

ADRENERGIC BETA-AGONISTS; BRONCHI; GLUCOCORTICOIDS; HUMANS; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, ADRENERGIC, BETA-2; TRANSCRIPTION, GENETIC;

EID: 37349117437     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.040121     Document Type: Article

References (42)

1. Abraham SM and Clark AR (2006) Dual-specificity phosphatase 1: a critical regulator of innate immune responses. Biochem Soc Trans 34:1018-1023.
2. Abraham SM, Lawrence T, Kleiman A, Warden P, Medghalchi M, Tuckermann J, Saklatvala J, and Clark AR (2006) Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med 203:1883-1889.
3. Aksoy MO, Mardini IA, Yang Y, Bin W, Zhou S, and Kelsen SG (2002) Glucocorticoid effects on the beta-adrenergic receptor-adenylyl cyclase system of human airway epithelium. J Allergy Clin Immunol 109:491-497.
4. Alheim K, Corness J, Samuelsson MK, Bladh LG, Murata T, Nilsson T, and Okret S (2003) Identification of a functional glucocorticoid response element in the promoter of the cyclin-dependent kinase inhibitor P57Kip2. J Mol Endocrinol 30:359-368.
5. Barnes PJ (2002) Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J 19:182-191.
6. Barnes PJ (2006) Corticosteroids: the drugs to beat. Eur J Pharmacol 533:2-14.
7. Bauvois B and Dauzonne D (2006) Aminopeptidase-N/CD13 (EC 3.4.11.2) Inhibitors: chemistry, biological evaluations, and therapeutic prospects. Med Res Rev 26:88-130.
8. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, and Vestbo J (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356:775-789.
9. Calverley PM, Boonsawat W, Cseke Z, Zhong N, Peterson S, and Olsson H (2003) Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 22:912-919.
10. Chivers JE, Cambridge LM, Catley MC, Mak JC, Donnelly LE, Barnes PJ, and Newton R (2004) Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin e release. Eur J Biochem 271:4042-4052.
11. Chivers JE, Gong W, King EM, Seybold J, Mak JC, Donnelly LE, Holden NS, and Newton R (2006) Analysis of the dissociated steroid, RU24858, does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids. Mol Pharmacol 70:2084-2095.
12. Eddleston J, Herschbach J, Wagelie-Steffen AL, Christiansen SC, and Zuraw BL (2007) The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J Allergy Clin Immunol 119:115-122.
13. Edwards MR, Johnson MW, and Johnston SL (2006) Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells. Am J Respir Cell Mol Biol 34:616-624.
14. 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 274:1005-1010.
15. Giembycz MA and Newton R (2006) Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways. Eur Respir J 27:1286-1306.
16. Greening AP, Ind PW, Northfield M, and Shaw G (1994) Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 344:219-224.
17. Howarth PH, Beckett P, and Dahl R (2000) The effect of long-acting beta2-agonists on airway inflammation in asthmatic patients. Respir Med 94 (Suppl F):S22-S25.
18. Korn SH, Jerre A, and Brattsand R (2001) Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J 17:1070-1077.
19. Maquerlot F, Galiacy S, Malo M, Guignabert C, Lawrence DA, d'Ortho MP, and Barlovatz-Meimon G (2006) Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing. Am J Pathol 169:1624-1632.
20. Meja KK, Catley MC, Cambridge LM, Barnes PJ, Lum H, Newton R, and Giembycz MA (2004) Adenovirus-mediated delivery and expression of a CAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the antiinflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89. J Pharmacol Exp Ther 309:833-844.
21. Mittelstadt PR and Ashwell JD (2001) Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 276:29603- 29610.
22. Newton R and Holden NS (2007) Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Mol Pharmacol 72:799-809.
23. Nordeen SK, Moyer ML, and Bona BJ (1994) The coupling of multiple signal transduction pathways with steroid response mechanisms. Endocrinology 134:1723-1732.
24. O'Byrne PM (2007) Acute asthma intervention: insights from the STAY study. J Allergy Clin Immunol 119:1332-1336.
25. O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekstrom T, and Bateman ED (2005) Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 171:129-136.
26. Pang L and Knox AJ (2000) Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells. Am J Respir Cell Mol Biol 23:79-85.
27. Pang L and Knox AJ (2001) Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids. FASEB J 15:261-269.
28. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, and Ullman A (1997) Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 337:1405-1411.
29. Rangarajan PN, Umesono K, and Evans RM (1992) Modulation of glucocorticoid receptor function by protein kinase A. Mol Endocrinol 6:1451-1457.
30. Roberts JA, Bradding P, Britten KM, Walls AF, Wilson S, Gratziou C, Holgate ST, and Howarth PH (1999) The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur Respir J 14:275-282.
31. Roth M, Johnson PR, Rudiger JJ, King GG, Ge Q, Burgess JK, Anderson G, Tamm M, and Black JL (2002) Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 360:1293-1299.
32. Samuelsson MK, Pazirandeh A, Davani B, and Okret S (1999) p57Kip2, a glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells. Mol Endocrinol 13:1811-1822.
33. Schwiebert LM, Stellato C, and Schleimer RP (1996) The epithelium as a target of glucocorticoid action in the treatment of asthma. Am J Respir Crit Care Med 154:S16-S19.
34. Shrewsbury S, Pyke S, and Britton M (2000) Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ 320:1368-1373.
35. Smoak K and Cidlowski JA (2006) Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling. Mol Cell Biol 26:9126-9135.
36. So AY, Chaivorapol C, Bolton EC, Li H, and Yamamoto KR (2007) Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 3:e94.
37. Stennard FA, Holloway AF, Hamilton J, and West AK (1994) Characterisation of six additional human metallothionein genes. Biochim Biophys Acta 1218:357-365.
38. Theilhaber J, Bushnell S, Jackson A, and Fuchs R (2001) Bayesian estimation of fold-changes in the analysis of gene expression: the PFOLD algorithm. J Comput Biol 8:585-614.
39. Usmani OS, Ito K, Maneechotesuwan K, Ito M, Johnson M, Barnes PJ, and Adcock IM (2005) Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am J Respir Crit Care Med 172:704-712.
40. Vayssiere BM, Dupont S, Choquart A, Petit F, Garcia T, Marchandeau C, Gronemeyer H, and Resche-Rigon (1997) Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit anti-inflammatory activity in vivo. Mol Endocrinol 11:1245-1255.
41. Westberry JM, Sadosky PW, Hubler TR, Gross KL, and Scammell JG (2006) Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51. J Steroid Biochem Mol Biol 100:34-41.
42. Woolcock A, Lundback B, Ringdal N, and Jacques LA (1996) Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 153:1481-1488.